Stocks were finished mixed Monday as the S&P 500 fell just short of a record close.
The U.S. and China - the world's two largest economies--postponed a weekend meeting to discuss progress of their phase one trade agreement.
Investors bought up shares from a variety of industries, including biotechnology, utilities, and gold. Here are some of the top gainers for Monday:
1. Imara | Percentage Increase Over 15%
Shares of Imara (IMRA) jumped after Citi analyst Yigal Nochomovitz upgraded the pharmaceutical company to buy from neutral with a price target of $30, down from $34. The company said it received encouraging news for IMR-687, its sickle cell disease treatment.
2. Azure Power Global | Percentage Increase Over 9%
Azure Power Global (AZRE) - Get Report advanced after the operator of solar-power plants in India beat Wall Street's first-quarter-earnings expectations. Adjusted earnings were 7 cents a share, ahead of the Zacks consensus estimate of a loss of 23 cents. Revenue totaled $52.2 million, up 16% from a year earlier and edging out the Zacks estimate of $51 million.
3. Barrick Gold | Percentage Increase Over 11%
Barrick Gold (GOLD) - Get Report shares were higher after Warren Buffet's Berkshire Hathaway (BRK.A) - Get Report took a new 1.2% stake in the gold mining company. Berkshire Hathaway also exited or reduced holdings in shares of financial companies in the quarter ended July 1.
4. Clovis Oncology | Percentage Increase Over 20%
Clovis Oncology (CLVS) - Get Report climbed after the biopharmaceutical company said a Phase II study of Rubraca, its treatment for metastatic castration-resistant prostate cancer, supported the May U.S. Food and Drug Administration accelerated approval of Rubraca for the treatment. The results were published in the Journal of Clinical Oncology.
5. GrowGeneration | Percentage Increase Over 22%
GrowGeneration (GRWG) - Get Report advanced after the specialty hydroponic and organic gardening retailer recently reported its 10th consecutive quarter of record revenue. Sales more than doubled from a year earlier to $43.5 million. Same-store sales were up 49% from a year ago.